Click Here for Articles About KRIS ALLEN
'American Idol' Winner KRIS ALLEN to Perform at 2014 Global Genes Tribute to Champions of Hope Gala
|VIDEO: Check Out New Promo for AMERICAN IDOL XIV - Who's Next?|
November 20, 2014
|Sony/ATV Signs 'All About That Bass' Songwriter Kevin Kadish|
October 16, 2014
|Caroline Glaser to Release EP 'Better Days Vol. 2', 9/16|
September 12, 2014
|Starpulse Premiers First Single 'Dream of You' from
CAROLINE GLASER's Upcoming EP|
August 13, 2014
|Related: KRIS ALLEN|
Global Genes announced today platinum recording artist
The evening will be a star-studded event with performances by platinum recording artist
"We are fortunate that the rare disease community looks forward to participating in this annual tribute," said Nicole Boice, Founder & CEO of Global Genes. "It continues to provide an opportunity for attendees to recognize their peers for their dedication, commitment, and innovative spirit that is helping achieve our common goal of eliminating the challenges of rare disease globally. We are honored and humbled to be in the company of these true Champions of Hope."
Sponsors of the 2014 Tribute to Champions of Hope Gala include: Walgreens, Alexion, Retrophin, Sciensus, Genzyme, Shire, Pfizer, Vanda Pharmaceuticals, Vidara Therapeutics, Biomarin, Recordati Rare Diseases, Novartis, Bio, Goldman Sachs, Siren Interactive, GlaxoSmithKline, Hyperion Therapeutics, Boehringer Ingleheim, Raptor Pharmaceutical Corp., AstraZeneca, Jazz Pharmaceuticals, Idis, Amicus Therapeutics, Auxilium, NEA, Cincinnati Children's, Lumena Pharmaceuticals, Ambry Genetics, illumina, Sigma-Tau Pharmaceuticals, Rocket Science, Aegerion Pharmaceuticals, Audentes, Sarepta Therapeutics, Synageva, Clementia, Watson Land Company, Print Technology Solutions, and PM Group.
For more information about the 2014 Tribute to Champions of Hope Gala, please visit: http://globalgenes.org/events
For more information about
For more information about Jessi Malay, please visit:
About Global Genes - Allies in Rare Disease
Global Genes is a leading rare disease patient advocacy organization. The group's mission is to eliminate the challenges of rare disease by providing patients with educational tools, building awareness, providing critical connections to people and resources, and through investment in technologies that will positively impact affected patients and families. Recognized worldwide by the Blue Denim Genes Ribbon, Global Genes unites experts, advocates, and patients of all ages to stand together in hope for treatments and cures for the estimated 7,000 rare and genetic diseases that impact approximately 30 million Americans and over 350 million people worldwide.
SOURCE: BUSINESS WIRE ©2014 Business Wire